Insider Trading
Filed: 2025-12-30
Key Insights
- Daniel P. O'Day, the Chairman and CEO of Gilead Sciences, sold 10,000 shares of common stock on December 29, 2025 pursuant to a pre-established 10b5-1 trading plan.
- The sale price range was $124.40 to $125.16 per share, and O'Day still holds 566,698 shares of Gilead stock directly.
- Insider selling can sometimes indicate management's view on the company's near-term prospects, though a 10b5-1 plan limits the interpretation of this transaction.